How do I install the Endo Cac Screening Borderline Intermediate Risk skill?

Run npx skillmds@latest add dromlakhani/endo-cac-screening-borderline-intermediate-risk in your terminal (requires Node.js), paste this page's agent-chat prompt into Claude, Cursor, or any MCP-connected agent, or download the SKILL.md file and copy it into your agent's skills directory.

Is Endo Cac Screening Borderline Intermediate Risk safe to use?

This skill has not completed SkillMD's automated safety review yet. Independent scanners report: SkillSpector: PASS, Skill Scanner: PASS. Capability flags: docs only. SkillMD never runs a skill's scripts for you; review the SKILL.md before installing.

Which AI agents work with Endo Cac Screening Borderline Intermediate Risk?

This skill is tagged as working with Claude Code, Claude.ai, OpenAI Codex. SKILL.md is an open format, so most agents that read a skills directory can load it too.

Is Endo Cac Screening Borderline Intermediate Risk free to use?

Yes. Installing skills from SkillMD is free, and the skill stays under its author's original license.

Who published Endo Cac Screening Borderline Intermediate Risk?

dromlakhani (@dromlakhani) published this skill. Their other Agent Skills are listed on their SkillMD profile.

Endo Cac Screening Borderline Intermediate Risk by dromlakhani

Name: Endo Cac Screening Borderline Intermediate Risk
Rating: 4.2 (5 reviews)
Author: dromlakhani

Endo Cac Screening Borderline Intermediate Risk

Suggests measuring coronary artery calcium to inform shared decision-making when statin treatment decisions are uncertain in adults with endocrine disorders at borderline or intermediate ASCVD risk. Triggers include patient has 10-year ASCVD risk between 5-19.9%, uncertain about statin initiation, and borderline or intermediate cardiovascular risk.

dromlakhani Updated Sep 8, 2026 10 repo stars

File contents

Coronary artery calcium scoring for borderline/intermediate ASCVD risk

STEP 1 — Gather Information

Collect lipid panel (LDL-C, HDL-C, triglycerides), calculate 10-year ASCVD risk using Pooled Cohort Equations, assess for risk-enhancing factors (e.g., elevated Lp(a) ≥50 mg/dL, family history of premature ASCVD, metabolic syndrome, CKD, chronic inflammatory conditions), and determine diabetes status. Proceed to calculate 10-year ASCVD risk.

STEP 2 — Rule In / Rule Out

Determine if 10-year ASCVD risk is between 5% and 19.9% and statin treatment decision is uncertain. If yes, proceed to step 3; if no, follow standard statin recommendation based on risk and risk-enhancing factors (statin not recommended for <5% risk unless risk-enhancing factors present; statin recommended for ≥20% risk). End with decision: proceed to CAC measurement or apply standard statin guidance.

STEP 3 — Classify or Stratify

Measure coronary artery calcium (CAC) score via non-contrast cardiac CT. Classify result as CAC = 0 or CAC > 0. End with action: If CAC = 0, note very low risk and consider repeat scanning; if CAC > 0, note increased risk and proceed to statin decision.

STEP 4 — Decide

For borderline risk (5-7.4%): if CAC = 0, statin generally not recommended; if CAC > 0, statin may be considered after clinician-patient discussion of risks/benefits. For intermediate risk (7.5-19.9%): if CAC = 0, statin generally not recommended; if CAC > 0, statin recommended after discussion. In both cases, if CAC = 0, repeat CAC in 3-5 years for borderline-intermediate risk patients. End with decision: initiate statin therapy or defer and repeat CAC.

Clinical Guardrails / Mimics / Pitfalls

Do not rely solely on CAC = 0 to withhold statin in familial hypercholesterolemia, advanced diabetes, or active smokers; CAC may underestimate risk in these groups. Do not use CAC to assess lipid-lowering treatment efficacy. Avoid CAC in patients already on aggressive statin therapy or with known high-risk genetic conditions (e.g., FH) where noncalcified plaque may be missed. Do not repeat CAC more frequently than every 3-5 years in borderline-intermediate risk without clinical indication.

Concrete Clinical Example

A 55-year-old woman with type 2 diabetes has LDL-C 130 mg/dL, HDL-C 45 mg/dL, TG 180 mg/dL, no smoking, BP 130/80. Pooled Cohort Equations give 10-year ASCVD risk 8.2% (intermediate risk). Clinician uncertain about statin initiation due to patient's preference for lifestyle first. CAC score is 0. According to guideline, statin generally not recommended; repeat CAC in 3-5 years. Patient opts for lifestyle re-evaluation.

Source: Lipid Management in Patients with Endocrine Disorders: An Endocrine Society Clinical Practice Guideline, Endocrine Society, 2020, doi:10.1210/clinem/dgaa674

TODO: consider adding scripts/calc.py for the endo-cac-screening-borderline-intermediate-risk calculator

---name: endo-cac-screening-borderline-intermediate-riskdescription: Suggests measuring coronary artery calcium to inform shared decision-making when statin treatment decisions are uncertain in adults with endocrine disorders at borderline or intermediate ASCVD risk. Triggers include patient has 10-year ASCVD risk between 5-19.9%, uncertain about statin initiation, and borderline or intermediate cardiovascular risk.---# Coronary artery calcium scoring for borderline/intermediate ASCVD risk## STEP 1 — Gather InformationCollect lipid panel (LDL-C, HDL-C, triglycerides), calculate 10-year ASCVD risk using Pooled Cohort Equations, assess for risk-enhancing factors (e.g., elevated Lp(a) ≥50 mg/dL, family history of premature ASCVD, metabolic syndrome, CKD, chronic inflammatory conditions), and determine diabetes status. Proceed to calculate 10-year ASCVD risk.## STEP 2 — Rule In / Rule OutDetermine if 10-year ASCVD risk is between 5% and 19.9% and statin treatment decision is uncertain. If yes, proceed to step 3; if no, follow standard statin recommendation based on risk and risk-enhancing factors (statin not recommended for <5% risk unless risk-enhancing factors present; statin recommended for ≥20% risk). End with decision: proceed to CAC measurement or apply standard statin guidance.## STEP 3 — Classify or StratifyMeasure coronary artery calcium (CAC) score via non-contrast cardiac CT. Classify result as CAC = 0 or CAC > 0. End with action: If CAC = 0, note very low risk and consider repeat scanning; if CAC > 0, note increased risk and proceed to statin decision.## STEP 4 — DecideFor borderline risk (5-7.4%): if CAC = 0, statin generally not recommended; if CAC > 0, statin may be considered after clinician-patient discussion of risks/benefits. For intermediate risk (7.5-19.9%): if CAC = 0, statin generally not recommended; if CAC > 0, statin recommended after discussion. In both cases, if CAC = 0, repeat CAC in 3-5 years for borderline-intermediate risk patients. End with decision: initiate statin therapy or defer and repeat CAC.## Clinical Guardrails / Mimics / PitfallsDo not rely solely on CAC = 0 to withhold statin in familial hypercholesterolemia, advanced diabetes, or active smokers; CAC may underestimate risk in these groups. Do not use CAC to assess lipid-lowering treatment efficacy. Avoid CAC in patients already on aggressive statin therapy or with known high-risk genetic conditions (e.g., FH) where noncalcified plaque may be missed. Do not repeat CAC more frequently than every 3-5 years in borderline-intermediate risk without clinical indication.## Concrete Clinical ExampleA 55-year-old woman with type 2 diabetes has LDL-C 130 mg/dL, HDL-C 45 mg/dL, TG 180 mg/dL, no smoking, BP 130/80. Pooled Cohort Equations give 10-year ASCVD risk 8.2% (intermediate risk). Clinician uncertain about statin initiation due to patient's preference for lifestyle first. CAC score is 0. According to guideline, statin generally not recommended; repeat CAC in 3-5 years. Patient opts for lifestyle re-evaluation.**Source:** Lipid Management in Patients with Endocrine Disorders: An Endocrine Society Clinical Practice Guideline, Endocrine Society, 2020, doi:10.1210/clinem/dgaa674> **TODO:** consider adding scripts/calc.py for the endo-cac-screening-borderline-intermediate-risk calculator

Frequently asked questions